Anne-Marie Koop

20 27. Marcus JT, Gan CTJ, Zwanenburg JJM, Boonstra A, Allaart CP, Götte MJW, Vonk- NoordegraafA. InterventricularMechanicalAsynchrony inPulmonaryArterialHypertension. Left-to-Right Delay in Peak Shortening Is Related to Right Ventricular Overload and Left Ventricular Underfilling. J Am Coll Cardiol 2008;51:750–757. 28. LahmT, Douglas IS, Archer SL, Bogaard HJ, Chesler NC, Haddad F, Hemnes AR, Kawut SM, Kline JA, Kolb TM, Mathai SC, Mercier O, Michelakis ED, Naeije R, Tuder RM, Ventetuolo CE, Vieillard-Baron A, Voelkel NF, Vonk-Noordegraaf A, Hassoun PM. Assessment of right ventricular function in the research setting: Knowledge gaps and pathways forward an official American thoracic society research statement. Am J Respir Crit Care Med 2018;198:e15–e43. 29. Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM. Right heart adaptation to pulmonary arterial hypertension: Physiology and pathobiology. J Am Coll Cardiol 2013;62:22–33. 30. Correia-Pinto J, Henriques-CoelhoT, Roncon-Albuquerque R, Leite-MoreiraAF. Differential right and left ventricular diastolic tolerance to acute afterload and NCX gene expression in wistar rats. Physiol Res 2006;55:513–526. 31. Rain S, Handoko ML, Trip P, Gan CT-J, Westerhof N, Stienen GJ, Paulus WJ, Ottenheijm CAC, Marcus JT, Dorfmüller P, Guignabert C, Humbert M, Macdonald P, Remedios C Dos, Postmus PE, Saripalli C, Hidalgo CG, Granzier HL, Vonk-Noordegraaf A, Velden J Van Der, Man FS De. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation F.S. De Man, Department of Pulmonology, VU University Medical Center, Institute for Cardiovascular Research, 1081 HV Amsterdam, Netherlands; 2013;128:2016–2025. 32. Rain S, Andersen S, Najafi A, Schultz JG, Silva Gonçalves Bós D Da, Handoko ML, Bogaard H-J, Vonk-Noordegraaf A, Andersen A, Velden J Van Der, Ottenheijm CAC, Man FS De. Right ventricular myocardial stiffness in experimental pulmonary arterial hypertension. Circ Hear Fail F.S. De Man, Department of Pulmonology, Vrije Universiteit University Medical Center, Amsterdam, Netherlands; 2016;9. 33. Bartelds B, Borgdorff M a., Smit-Van Oosten A, Takens J, Boersma B, Nederhoff MG, Elzenga NJ, Gilst WH Van, Windt LJ De, Berger RMF. Differential responses of the right ventricle to abnormal loading conditions in mice: Pressure vs. volume load. Eur J Heart Fail 2011;13:1275–1282. 34. Rossi MA, Carillo S V. Cardiac hypertrophy due to pressure and volume overload: distinctly different biological phenomena? Int J Cardiol 1991;31:133–141. 35. Grossman W. Cardiac hypertrophy: Useful adaptation or pathologic process? Am J Med 1980;69:576–584. 36. Yeves AM, Villa-Abrille MC, Pérez NG, Medina AJ, Escudero EM, Ennis IL. Physiological cardiac hypertrophy: Critical role of AKT in the prevention of NHE-1 hyperactivity. J Mol Cell Cardiol Elsevier Ltd; 2014;76:186–195. 37. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, Muslin AJ. Akt1 is required for physiological cardiac growth. Circulation 2006;113:2097–2104. 38. Zou Y, Hiroi Y, Uozumi H, Takimoto E, Toko H, ZhuW, Kudoh S, Mizukami M, Shimoyama M, Shibasaki F, Nagai R, Yazaki Y, Komuro I. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy. Circulation 2001;104:97–101.